University of California San Francisco

Publications

  1. Impact of Coronary Artery Stenting on Perioperative Mortality and Complications in Patients Undergoing Pancreaticoduodenectomy.
    Wong P, Tran TB, Pollini T, Hernandez S, Zampese M, Todeschini L, Aguilar LL, Maker VK, Maker AV
    J Gastrointest Surg. 2025 Mar 19; 102020.; 
    PubMed
  2. Perioperative Broad-spectrum Antibiotics are Associated With Decreased Surgical Site Infections Compared to 1st-3rd Generation Cephalosporins After Open Pancreaticoduodenectomy in Patients With Jaundice or a Biliary Stent: Erratum.
    Kone LB, Perez-Iglesias CT, Banulescu M, Maker VK, Maker AV
    Ann Surg. 2025 04 01; 281(4):e5.; 
    PubMed
  3. Delayed Gastric Emptying After Whipple: Pyloric Manipulation Will Not Solve It, but the Body Compensates.
    Maker AV
    Ann Surg Oncol. 2025 Jun; 32(6):3861-3862.; 
    PubMed
  4. ASO Visual Abstract: Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma.
    Wong P, Pollini T, Adam MA, Alseidi A, Corvera CU, Hirose K, Kirkwood KS, Nakakura EK, Thornblade L, Maker AV
    Ann Surg Oncol. 2025 Jan; 32(1):536.; 
    PubMed
  5. ASO Visual Abstract: Essential Elements in Synoptic Operative Reports for Hepato-Pancreato-Biliary Cancer Surgery-An HPB/CGSO Training Program Survey.
    Kone LB, Seok D, Kimble MM, Maker AV, Patil S, Mittal V, Jacobs M
    Ann Surg Oncol. 2024 Dec 02.; 
    PubMed
  6. Essential Elements in Synoptic Operative Reports for Hepato-Pancreato-Biliary Cancer Surgery: An HPB/CGSO Training Program Survey.
    Kone LB, Seok D, Kimble MM, Maker AV, Patil S, Mittal V, Jacobs M
    Ann Surg Oncol. 2025 Jan; 32(1):382-390.; 
    PubMed
  7. Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC).
    Yin H, Romero-Hernandez F, Ganjouei AA, Wang JJ, Brown A, Hirose K, Maker AV, Nakakura E, Corvera C, Kirkwood KS, Wilhelm A, Peng JS, Alseidi A, Adam MA
    Curr Oncol. 2024 08 28; 31(9):5008-5020.; 
    PubMed
  8. Graft choice in pancreatectomy with vascular resection: equivalent safety in selected patients.
    Hoffman D, Ganjouei AA, Hernandez FR, Ifuku K, Miller P, Glencer A, Corvera C, Kirkwood K, Alseidi A, Adam M, Maker A, Hirose K, Hirose R, Nakakura EK
    J Gastrointest Surg. 2024 Nov; 28(11):1799-1804.; 
    PubMed
  9. ASO Author Reflections: Is Adjuvant Therapy Necessary for All Patients with Invasive Mucinous Cystic Neoplasms of the Pancreas? Let's De-escalate.
    Wong P, Pollini T, Maker AV
    Ann Surg Oncol. 2024 Nov; 31(12):8352-8353.; 
    PubMed
  10. ASO Visual Abstract: Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.
    Miller PN, Romero-Hernandez F, Calthorpe L, Wang JJ, Kim SS, Corvera CU, Hirose K, Kirkwood KS, Hirose R, Maker AV, Alseidi AA, Adam MA, Kim GE, Tempero MA, Ko AH, Nakakura EK
    PubMed
  11. Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma.
    Wong P, Pollini T, Adam MA, Alseidi A, Corvera CU, Hirose K, Kirkwood KS, Nakakura EK, Thornblade L, Maker AV
    Ann Surg Oncol. 2024 Nov; 31(12):8276-8286.; 
    PubMed
  12. Multi-omic profiling of intraductal papillary neoplasms of the pancreas reveals distinct expression patterns and potential markers of progression.
    Wang Y, Lih TM, Lee JW, Ohtsuka T, Hozaka Y, Mino-Kenudson M, Adsay NV, Luchini C, Scarpa A, Maker AV, Kim GE, Paulino J, Chen L, Jiao L, Sun Z, Goodman D, Pflüger MJ, Roberts NJ, Matthaei H, Wood LD, Furukawa T, Zhang H, Hruban RH
    bioRxiv. 2024 Jul 07.; 
    PubMed
  13. The impact of the California state lockdown during the COVID-19 pandemic on management of patients with pancreatic ductal adenocarcinoma.
    Oviedo P, Burns S, Chen WP, Mandl HK, Rosso C, Radgoudarzi N, Crosetti A, Zamora S, Perry LM, Bold RJ, Labora AN, Donahue TR, Maker A, Valerin JB, Zell JA, White RR
    J Surg Oncol. 2024 Aug; 130(2):276-283.; 
    PubMed
  14. Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.
    Miller PN, Romero-Hernandez F, Calthorpe L, Wang JJ, Kim SS, Corvera CU, Hirose K, Kirkwood KS, Hirose R, Maker AV, Alseidi AA, Adam MA, Kim GE, Tempero MA, Ko AH, Nakakura EK
    Ann Surg Oncol. 2024 Sep; 31(9):6147-6156.; 
    PubMed
  15. Insights on liver-directed surgical innovations, targeted therapies, and immunotherapy for biliary tract cancer: navigating the new European Society for Medical Oncology (ESMO) Clinical Practice Guidelines.
    Maker AV
    Hepatobiliary Surg Nutr. 2024 Jun 01; 13(3):516-519.; 
    PubMed
  16. Pancreas Cyst Diagnosis and Advances in Cyst Fluid Analysis.
    Pollini T, Todeschini L, Maker AV
    Surg Clin North Am. 2024 Oct; 104(5):965-974.; 
    PubMed
  17. Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors.
    Wong P, Wisneski AD, Tsai KK, Chang TT, Hirose K, Nakakura EK, Daud AI, Maker AV, Corvera CU
    World J Surg Oncol. 2024 Mar 11; 22(1):77.; 
    PubMed
  18. Intraoperative hepatic artery infusion pump perfusion testing with indocyanine green near-infrared imaging offers multiple potential advantages.
    Wong P, Hoffman D, Pollini T, Zampese M, Corvera CU, Maker AV
    J Gastrointest Surg. 2024 Apr; 28(4):598-599.; 
    PubMed
  19. "Mickey Mouse sign" to identify and remove cystic duct stones in postcholecystectomy syndrome.
    O'Rear J, Wong P, Pollini T, Maker VK, Maker AV
    J Gastrointest Surg. 2024 Mar; 28(3):334-335.; 
    PubMed
  20. Improved survival of patients receiving immunotherapy and chemotherapy following curative-intent resection of colorectal liver metastases.
    Pollini T, Tran T, Wong P, Adam MA, Alseidi A, Corvera C, Hirose K, Nakakura E, Warren R, Maker VK, Maker AV
    J Gastrointest Surg. 2024 Mar; 28(3):246-251.; 
    PubMed
  21. Educating Cancer-Associated Fibroblasts (CAFs): Are They the Student or the Teacher?
    Maker AV, Karakousis G
    Ann Surg Oncol. 2024 Apr; 31(4):2181-2182.; 
    PubMed
  22. Surgical Cancer Care in Safety-Net Hospitals: a Systematic Review.
    Wong P, Victorino GP, Sadjadi J, Knopf K, Maker AV, Thornblade LW
    J Gastrointest Surg. 2023 12; 27(12):2920-2930.; 
    PubMed
  23. Impact of safety-net hospital burden on achievement of textbook oncologic outcomes following resection in for stage I-IV colorectal cancer.
    Wong P, Victorino GP, Miraflor E, Alseidi A, Maker AV, Thornblade LW
    J Surg Oncol. 2024 Feb; 129(2):284-296.; 
    PubMed
  24. A Machine Learning Approach to Predict Postoperative Pancreatic Fistula After Pancreaticoduodenectomy Using Only Preoperatively Known Data.
    Ashraf Ganjouei A, Romero-Hernandez F, Wang JJ, Casey M, Frye W, Hoffman D, Hirose K, Nakakura E, Corvera C, Maker AV, Kirkwood KS, Alseidi A, Adam MA
    Ann Surg Oncol. 2023 Nov; 30(12):7738-7747.; 
    PubMed
  25. ASO Visual Abstract: National Practice Patterns in Malignant Peritoneal Mesothelioma-Updates in Management and Survival.
    Calthorpe L, Romero-Hernandez F, Casey M, Nunez M, Conroy PC, Hirose K, Kim A, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA
    Ann Surg Oncol. 2023 Aug; 30(8):5131.; 
    PubMed
  26. Non-Canonical Activin A Signaling Stimulates Context-Dependent and Cellular-Specific Outcomes in CRC to Promote Tumor Cell Migration and Immune Tolerance.
    Wiley MB, Bauer J, Mehrotra K, Zessner-Spitzenberg J, Kolics Z, Cheng W, Castellanos K, Nash MG, Gui X, Kone L, Maker AV, Qiao G, Reddi D, Church DN, Kerr RS, Kerr DJ, Grippo PJ, Jung B
    Cancers (Basel). 2023 May 31; 15(11).; 
    PubMed
  27. National Practice Patterns in Malignant Peritoneal Mesothelioma: Updates in Management and Survival.
    Calthorpe L, Romero-Hernandez F, Casey M, Nunez M, Conroy PC, Hirose K, Kim A, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA
    Ann Surg Oncol. 2023 Aug; 30(8):5119-5129.; 
    PubMed
  28. It is not necessary to resect all mucinous cystic neoplasms of the pancreas: current guidelines do not reflect the actual risk of malignancy.
    Pollini T, Marchegiani G, Facciorusso A, Balduzzi A, Biancotto M, Bassi C, Maker AV, Salvia R
    HPB (Oxford). 2023 07; 25(7):747-757.; 
    PubMed
  29. Drain Placement After Pancreatic Resection: Friend or Foe For Surgical Site Infections?
    Pollini T, Wong P, Kone LB, Khoury RE, Kabir C, Maker VK, Banulescu M, Maker AV
    J Gastrointest Surg. 2023 04; 27(4):724-729.; 
    PubMed
  30. Hypertension Requiring Medication Use: a Silent Predictor of Poor Outcomes After Pancreaticoduodenectomy.
    Lin JJ, Conroy PC, Romero-Hernandez F, Yilma M, Feng J, Hirose K, Nakakura E, Maker AV, Corvera C, Kirkwood K, Alseidi A, Adam MA
    J Gastrointest Surg. 2023 02; 27(2):328-336.; 
    PubMed
  31. The Landmark Series: Intraductal Papillary Mucinous Neoplasms of the Pancreas-From Prevalence to Early Cancer Detection.
    Pollini T, Wong P, Maker AV
    Ann Surg Oncol. 2023 Mar; 30(3):1453-1462.; 
    PubMed
  32. Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States.
    Calthorpe L, Romero-Hernandez F, Miller P, Conroy PC, Hirose K, Kim A, Kirkwood K, Nakakura E, Corvera C, Maker AV, Alseidi A, Adam MA
    Cancers (Basel). 2022 Dec 30; 15(1).; 
    PubMed
  33. Hand-Assisted Versus Pure Minimally-Invasive Distal Pancreatectomy: Is There a Downside to Lending a Hand?
    Miller PN, Romero-Hernandez F, Conroy P, Calthorpe L, Yilma M, Mohamedaly S, Kelly YM, Feng J, Hirose K, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA
    World J Surg. 2023 03; 47(3):750-758.; 
    PubMed
  34. Minimally Invasive Distal Pancreatectomy Techniques: A Contemporary Analysis Exploring Trends, Similarities, and Differences to Open Surgery.
    Romero-Hernandez F, Mohamedaly S, Miller P, Rodriguez N, Calthorpe L, Conroy PC, Ganjouei AA, Hirose K, Maker AV, Nakakura E, Corvera C, Kirkwood KS, Alseidi A, Adam MA
    Cancers (Basel). 2022 Nov 16; 14(22).; 
    PubMed
  35. The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms.
    Pollini T, Adsay V, Capurso G, Dal Molin M, Esposito I, Hruban R, Luchini C, Maggino L, Matthaei H, Marchegiani G, Scarpa A, Wood LD, Bassi C, Salvia R, Mino-Kenudson M, Maker AV
    Lancet Gastroenterol Hepatol. 2022 12; 7(12):1141-1150.; 
    PubMed
  36. Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: An US safety net collaborative analysis.
    Leder Macek AJ, Wang A, Turgeon MK, Lee RM, Russell MC, Porembka MR, Alterio R, Ju M, Kronenfeld J, Goel N, Datta J, Maker AV, Fernandez M, Richter H, Berman RS, Correa-Gallego C, Lee AY
    J Surg Oncol. 2022 Sep; 126(4):649-657.; 
    PubMed
  37. Physical exam reveals etiology of liver and pancreatic tumors.
    Kone LB, Maker AV
    Surgery. 2022 10; 172(4):e43-e44.; 
    PubMed
  38. Langer's arch: An anatomic variant complicating axillary node dissection.
    Baskin AS, Wang K, Maker AV
    Surgery. 2022 08; 172(2):e19-e20.; 
    PubMed
  39. Robotic Surgery for Biliary Tract Cancer.
    Kone LB, Bystrom PV, Maker AV
    Cancers (Basel). 2022 Feb 18; 14(4).; 
    PubMed
  40. LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer.
    Qiao G, Kone LB, Phillips EH, Lee SS, Brown GE, Khetani SR, Thakur A, Lum LG, Prabhakar BS, Maker AV
    Oncogene. 2022 04; 41(14):2054-2068.; 
    PubMed
  41. Clinical Presentation Patterns and Survival Outcomes of Hispanic Patients With Gastric Cancer.
    Vitiello GA, Hani L, Wang A, Porembka MR, Alterio R, Ju M, Turgeon MK, Lee RM, Russell MC, Kronenfeld J, Goel N, Datta J, Maker AV, Fernandez M, Richter H, Correa-Gallego C, Berman RS, Lee AY
    J Surg Res. 2021 12; 268:606-615.; 
    PubMed
  42. Attrition during neoadjuvant chemotherapy for gastric adenocarcinoma is associated with decreased survival: A United States Safety-Net Collaborative analysis.
    Kronenfeld JP, Collier AL, Turgeon MK, Ju M, Alterio R, Wang A, Fernandez M, Porembka MR, Richter H, Lee AY, Russell MC, Merchant NB, Maker AV, Datta J
    J Surg Oncol. 2021 Dec; 124(8):1317-1328.; 
    PubMed
  43. The Evolution of Cancer Immunotherapy.
    Khan M, Maker AV, Jain S
    Vaccines (Basel). 2021 Jun 08; 9(6).; 
    PubMed
  44. Is there a difference in utilization of a perioperative treatment approach for gastric cancer between safety net hospitals and tertiary referral centers?
    Turgeon MK, Lee RM, Keilson JM, Ju MR, Porembka MR, Alterio RE, Kronenfeld J, Datta J, Goel N, Wang A, Lee AY, Fernandez M, Richter H, Maker AV, Maithel SK, Russell MC
    J Surg Oncol. 2021 Sep; 124(4):551-559.; 
    PubMed
  45. Race and Gender Differences in Awareness of Colorectal Cancer Screening Tests and Guidelines Among Recently Diagnosed Colon Cancer Patients in an Urban Setting.
    Carnahan LR, Jones L, Brewer KC, Watts EA, Peterson CE, Ferrans CE, Cipriano-Steffens T, Polite B, Maker AV, Chowdhery R, Molina Y, Rauscher GH
    J Cancer Educ. 2021 06; 36(3):567-575.; 
    PubMed
  46. Combining On-Table Embolization with Immediate Resection to Safely Excise Giant Hepatic Hemangiomas.
    Maker AV, Al Rameni D, Prabhakar N
    J Gastrointest Surg. 2021 06; 25(6):1651-1653.; 
    PubMed
  47. Combination Immunotherapy With LIGHT and Interleukin-2 Increases CD8 Central Memory T-Cells In Vivo.
    Fernandez MF, Qiao G, Tulla K, Prabhakar BS, Maker AV
    PubMed
  48. ASO Author Reflections: How Can We Improve the Postoperative Experience for Our Pancreatic Cancer Patients? A Practical Technique to Optimize Pain Control After Major Abdominal Surgery.
    Maker AV
    Ann Surg Oncol. 2021 Apr; 28(4):2296-2298.; 
    PubMed
  49. Surgeon-Placed Continuous Wound Infusion Pain Catheters Markedly Decrease Narcotic Use and Improve Outcomes After Pancreatic Tumor Resection.
    Kone LB, Kunda NM, Tran TB, Maker AV
    Ann Surg Oncol. 2021 Apr; 28(4):2287-2295.; 
    PubMed
  50. Epidural Analgesia Is Associated with Prolonged Length of Stay After Open HPB Surgery in Over 27,000 Patients.
    Kone LB, Maker VK, Banulescu M, Maker AV
    J Gastrointest Surg. 2021 07; 25(7):1716-1726.; 
    PubMed
  51. Perioperative Broad-spectrum Antibiotics are Associated With Decreased Surgical Site Infections Compared to 1st-3rd Generation Cephalosporins After Open Pancreaticoduodenectomy in Patients With Jaundice or a Biliary Stent.
    Kone LB, Torres C, Banulescu M, Maker VK, Maker AV
    Ann Surg. 2022 06 01; 275(6):1175-1183.; 
    PubMed
  52. Should Drains Suck? A Propensity Score Analysis of Closed-Suction Versus Closed-Gravity Drainage After Pancreatectomy.
    Kone LB, Maker VK, Banulescu M, Maker AV
    J Gastrointest Surg. 2021 05; 25(5):1224-1232.; 
    PubMed
  53. Oncolytic adenovirus encoding LIGHT (TNFSF14) inhibits tumor growth via activating anti-tumor immune responses in 4T1 mouse mammary tumor model in immune competent syngeneic mice.
    Dai S, Lv Y, Xu W, Yang Y, Liu C, Dong X, Zhang H, Prabhakar BS, Maker AV, Seth P, Wang H
    Cancer Gene Ther. 2020 12; 27(12):923-933.; 
    PubMed
  54. Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations.
    Bartlett DL, Howe JR, Chang G, Crago A, Hogg M, Karakousis G, Levine E, Maker A, Mamounas E, McGuire K, Merchant N, Shibata D, Sohn V, Solorzano C, Turaga K, White R, Yang A, Yoon S, Society of Surgical Oncology
    Ann Surg Oncol. 2020 Jun; 27(6):1717-1720.; 
    PubMed
  55. A propensity score analysis of over 12,000 pancreaticojejunal anastomoses after pancreaticoduodenectomy: does technique impact the clinically relevant fistula rate?
    Kone LB, Maker VK, Banulescu M, Maker AV
    HPB (Oxford). 2020 10; 22(10):1394-1401.; 
    PubMed
  56. MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer.
    Saini S, Sripada L, Tulla K, Qiao G, Kunda N, Maker AV, Prabhakar BS
    Endocr Relat Cancer. 2019 06 01; 26(6):551-563.; 
    PubMed
  57. Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential.
    Maker AV, Hu V, Kadkol SS, Hong L, Brugge W, Winter J, Yeo CJ, Hackert T, Büchler M, Lawlor RT, Salvia R, Scarpa A, Bassi C, Green S
    J Am Coll Surg. 2019 05; 228(5):721-729.; 
    PubMed
  58. Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer.
    Saini S, Sripada L, Tulla K, Kumar P, Yue F, Kunda N, Maker AV, Prabhakar BS
    Cell Death Dis. 2019 02 13; 10(2):145.; 
    PubMed
  59. Impact of Immunotherapy after Resection of Pancreatic Cancer.
    Tran TB, Maker VK, Maker AV
    J Am Coll Surg. 2019 07; 229(1):19-27.e1.; 
    PubMed
  60. Molecular aberrations and signaling cascades implicated in the pathogenesis of anaplastic thyroid cancer.
    Saini S, Maker AV, Burman KD, Prabhakar BS
    Biochim Biophys Acta Rev Cancer. 2019 12; 1872(2):188262.; 
    PubMed
  61. Management of asymptomatic, well-differentiated PNETs: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary Association.
    Mansour JC, Chavin K, Morris-Stiff G, Warner SG, Cardona K, Fong ZV, Maker A, Libutti SK, Warren R, St Hill C, Celinski S, Newell P, Ly QP, Howe J, Coburn N
    HPB (Oxford). 2019 05; 21(5):515-523.; 
    PubMed
  62. Does attending a Delphi consensus conference impact surgeon attitudes? Survey results from the Americas HepatoPancreatoBiliary Association consensus conference on small asymptomatic pancreatic neuroendocrine tumors.
    Maker AV, Tran TB, Coburn N, Fong ZV, Cardona K, Newell P, Morris-Stiff G, Chavin K, Mansour J, members of the AHPBA Research Committee Consensus Conference
    HPB (Oxford). 2019 05; 21(5):524-530.; 
    PubMed
  63. Therapeutic advances in anaplastic thyroid cancer: a current perspective.
    Saini S, Tulla K, Maker AV, Burman KD, Prabhakar BS
    Mol Cancer. 2018 10 23; 17(1):154.; 
    PubMed
  64. ASO Author Reflections: Improving Identification of Intraductal Papillary Mucinous Neoplasm Patients at Risk-Current Status and the Role of IPMN Molecular Biomarkers.
    Maker AV
    Ann Surg Oncol. 2018 12; 25(Suppl 3):818-819.; 
    PubMed
  65. Identification of a Novel OX40L+ Dendritic Cell Subset That Selectively Expands Regulatory T cells.
    Marinelarena A, Bhattacharya P, Kumar P, Maker AV, Prabhakar BS
    Sci Rep. 2018 10 08; 8(1):14940.; 
    PubMed
  66. KRASG12D and TP53R167H Cooperate to Induce Pancreatic Ductal Adenocarcinoma in Sus scrofa Pigs.
    Principe DR, Overgaard NH, Park AJ, Diaz AM, Torres C, McKinney R, Dorman MJ, Castellanos K, Schwind R, Dawson DW, Rana A, Maker A, Munshi HG, Rund LA, Grippo PJ, Schook LB
    Sci Rep. 2018 08 22; 8(1):12548.; 
    PubMed
  67. Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases.
    Qin J, Kunda NM, Qiao G, Tulla K, Prabhakar BS, Maker AV
    J Surg Res. 2019 01; 233:57-64.; 
    PubMed
  68. Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation.
    Kumar P, Marinelarena A, Raghunathan D, Ragothaman VK, Saini S, Bhattacharya P, Fan J, Epstein AL, Maker AV, Prabhakar BS
    Cell Mol Immunol. 2019 02; 16(2):138-153.; 
    PubMed
  69. What is the Incidence of Malignancy in Resected Intraductal Papillary Mucinous Neoplasms? An Analysis of Over 100 US Institutions in a Single Year.
    Khoury RE, Kabir C, Maker VK, Banulescu M, Wasserman M, Maker AV
    Ann Surg Oncol. 2018 Jun; 25(6):1746-1751.; 
    PubMed
  70. Do Drains Contribute to Pancreatic Fistulae? Analysis of over 5000 Pancreatectomy Patients.
    El Khoury R, Kabir C, Maker VK, Banulescu M, Wasserman M, Maker AV
    J Gastrointest Surg. 2018 06; 22(6):1007-1015.; 
    PubMed
  71. Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas.
    Tulla KA, Maker AV
    Langenbecks Arch Surg. 2018 Mar; 403(2):151-194.; 
    PubMed
  72. Port-Site Resection in the Surgical Management of Incidental Gallbladder Cancer: A Still Inconclusive Question: A Reply.
    Maker AV, Jarnagin WR
    Ann Surg Oncol. 2017 12; 24(Suppl 3):647-648.; 
    PubMed
  73. Examining racial disparities in colon cancer clinical delay in the Colon Cancer Patterns of Care in Chicago study.
    Jones LA, Ferrans CE, Polite BN, Brewer KC, Maker AV, Pauls HA, Rauscher GH
    Ann Epidemiol. 2017 11; 27(11):731-738.e1.; 
    PubMed
  74. The Oncopig Cancer Model: An Innovative Large Animal Translational Oncology Platform.
    Schachtschneider KM, Schwind RM, Newson J, Kinachtchouk N, Rizko M, Mendoza-Elias N, Grippo P, Principe DR, Park A, Overgaard NH, Jungersen G, Garcia KD, Maker AV, Rund LA, Ozer H, Gaba RC, Schook LB
    Front Oncol. 2017; 7:190.; 
    PubMed
  75. PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells.
    Alharshawi K, Marinelarena A, Kumar P, El-Sayed O, Bhattacharya P, Sun Z, Epstein AL, Maker AV, Prabhakar BS
    Sci Rep. 2017 07 26; 7(1):6594.; 
    PubMed
  76. Perioperative management of endocrine insufficiency after total pancreatectomy for neoplasia.
    Maker AV, Sheikh R, Bhagia V, Diabetes Control and Complications Trial (DCCT) Research Group
    Langenbecks Arch Surg. 2017 Sep; 402(6):873-883.; 
    PubMed
  77. A Technique to Define Extrahepatic Biliary Anatomy Using Robotic Near-Infrared Fluorescent Cholangiography.
    Maker AV, Kunda N
    J Gastrointest Surg. 2017 Nov; 21(11):1961-1962.; 
    PubMed
  78. Targeting cancer with tumor-specific therapeutic strategies-metabolic reprogramming beyond the Warburg effect.
    Grippo P, Maker AV
    Transl Cancer Res. 2017 May; 6(Suppl 3):S585-S586.; 
    PubMed
  79. Mitochondrial protein 18 (MTP18) plays a pro-apoptotic role in chemotherapy-induced gastric cancer cell apoptosis.
    Aung LHH, Li R, Prabhakar BS, Maker AV, Li P
    Oncotarget. 2017 Aug 22; 8(34):56582-56597.; 
    PubMed
  80. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
    Ejaz A, Casadaban L, Maker AV
    J Surg Res. 2017 07; 215:12-20.; 
    PubMed
  81. LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases.
    Qiao G, Qin J, Kunda N, Calata JF, Mahmud DL, Gann P, Fu YX, Rosenberg SA, Prabhakar BS, Maker AV
    Cancer Res. 2017 04 15; 77(8):1880-1891.; 
    PubMed
  82. Isolated Pancreatic Uncinate Duct IPMN.
    Maker AV, Maker VK
    J Gastrointest Surg. 2017 04; 21(4):744-745.; 
    PubMed
  83. Colon cancer cell treatment with rose bengal generates a protective immune response via immunogenic cell death.
    Qin J, Kunda N, Qiao G, Calata JF, Pardiwala K, Prabhakar BS, Maker AV
    Cell Death Dis. 2017 02 02; 8(2):e2584.; 
    PubMed
  84. Can Colon Cancer Recurrence and Metastases Be Determined After Surgical Resection Using a Gene Expression Signature?
    Casadaban L, Maker AV
    J Clin Oncol. 2017 04 20; 35(12):1372-1373.; 
    PubMed
  85. Gene-expression profiling to predict responsiveness to immunotherapy.
    Jamieson NB, Maker AV
    Cancer Gene Ther. 2017 Mar; 24(3):134-140.; 
    PubMed
  86. Targeting the metabolic pathway of human colon cancer overcomes resistance to TRAIL-induced apoptosis.
    Carr RM, Qiao G, Qin J, Jayaraman S, Prabhakar BS, Maker AV
    Cell Death Discov. 2016; 2:16067.; 
    PubMed
  87. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
    Casadaban L, Rauscher G, Aklilu M, Villenes D, Freels S, Maker AV
    Cancer. 2016 Nov 15; 122(21):3277-3287.; 
    PubMed
  88. Techniques to perform robotic left adrenalectomy in the obese patient.
    Maker AV, Maker VK
    Surg Endosc. 2017 02; 31(2):950.; 
    PubMed
  89. Hepatectomy After Yttrium-90 (Y90) Radioembolization-Induced Liver Fibrosis.
    Maker AV, August C, Maker VK, Weisenberg E
    J Gastrointest Surg. 2016 Apr; 20(4):869-70.; 
    PubMed
  90. A Minimally Invasive Technique to Obtain Optimal Tumor Margins in Anatomically Confined Locations Using a Contoured Stapler.
    Maker AV, Valbuena V, Maker VK
    Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S340.; 
    PubMed
  91. Precise identification of immunotherapeutic targets for solid malignancies using clues within the tumor microenvironment-Evidence to turn on the LIGHT.
    Maker AV
    Oncoimmunology. 2016; 5(1):e1069937.; 
    PubMed
  92. The Potential of Intralesional Rose Bengal to Stimulate T-Cell Mediated Anti-Tumor Responses.
    Maker AV, Prabhakar B, Pardiwala K
    J Clin Cell Immunol. 2015 Aug; 6(4).; 
    PubMed
  93. Techniques to perform a laparoscopic right adrenalectomy for metastases abutting the liver, renal vein, and posterior vena cava.
    Maker AV, Carr R
    Surg Endosc. 2016 Mar; 30(3):1226.; 
    PubMed
  94. Symptomatic Massive Splenomegaly in Persistent Polyclonal B-cell Lymphocytosis Requiring Splenectomy.
    Bhagwandin SB, Weisenberg ES, Ozer H, Maker AV
    Open J Clin Med Case Rep. 2015; 1(3).; 
    PubMed
  95. Tailoring GIST therapy—biology is still king.
    Maker AV
    JAMA Surg. 2015 Apr; 150(4):306-7.; 
    PubMed
  96. Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features.
    Kopanja D, Pandey A, Kiefer M, Wang Z, Chandan N, Carr JR, Franks R, Yu DY, Guzman G, Maker A, Raychaudhuri P
    J Hepatol. 2015 Aug; 63(2):429-36.; 
    PubMed
  97. Simultaneous Occurrence of Glandular and Neuroendocrine Components in Lymph Node Metastasis of Gastric MANEC.
    August C, Maker AV, Weisenberg E
    Int J Surg Pathol. 2015 Aug; 23(5):375-6.; 
    PubMed
  98. Closure of Melanoma Defects on the Sole of the Foot Using Glaborous Skin: The End of the Flap?
    Maker AV, Iteld L
    Ann Surg Oncol. 2015 Nov; 22(12):4081-2.; 
    PubMed
  99. Operative management of portal annular pancreas during pancreaticoduodenectomy.
    Pardiwala KH, Maker AV
    Surgery. 2016 Mar; 159(3):972-4.; 
    PubMed
  100. Genetic evidence that intratumoral T-cell proliferation and activation are associated with recurrence and survival in patients with resected colorectal liver metastases.
    Maker AV, Ito H, Mo Q, Weisenberg E, Qin LX, Turcotte S, Maithel S, Shia J, Blumgart L, Fong Y, Jarnagin WR, DeMatteo RP, D'Angelica MI
    Cancer Immunol Res. 2015 Apr; 3(4):380-8.; 
    PubMed
  101. Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms.
    Maker AV, Carrara S, Jamieson NB, Pelaez-Luna M, Lennon AM, Dal Molin M, Scarpa A, Frulloni L, Brugge WR
    J Am Coll Surg. 2015 Feb; 220(2):243-53.; 
    PubMed
  102. Appendicitis secondary to metastatic melanoma: review of the National Institutes of Health experience.
    Kitano M, Maker AV, Lanier BJ, Danforth DN, Kammula US
    JAMA Surg. 2014 Jul; 149(7):735-8.; 
    PubMed
  103. Calcifying fibrous tumor of the small intestine associated with Castleman-like lymphadenopathy.
    Valladolid G, Weisenberg E, Sundaresan R, Maker AV
    J Gastrointest Surg. 2014 Jun; 18(6):1205-8.; 
    PubMed
  104. Dedifferentiated gastrointestinal stromal tumor arising de novo from the small intestine.
    Choi JJ, Sinada-Bottros L, Maker AV, Weisenberg E
    Pathol Res Pract. 2014 Apr; 210(4):264-6.; 
    PubMed
  105. IG20/MADD plays a critical role in glucose-induced insulin secretion.
    Li LC, Wang Y, Carr R, Haddad CS, Li Z, Qian L, Oberholzer J, Maker AV, Wang Q, Prabhakar BS
    Diabetes. 2014 May; 63(5):1612-23.; 
    PubMed
  106. Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer.
    Ito H, Mo Q, Qin LX, Viale A, Maithel SK, Maker AV, Shia J, Kingham P, Allen P, DeMatteo RP, Fong Y, Jarnagin WR, D'Angelica M
    PLoS One. 2013; 8(12):e81680.; 
    PubMed
  107. Benign adrenal hemangiomas may mimic metastases on PET.
    Calata JF, Sukerkar AN, August CZ, Maker AV
    Clin Nucl Med. 2013 Nov; 38(11):888-90.; 
    PubMed
  108. Management of patients with abdominal malignancy after remote jejunoileal bypass: surgical considerations decades later.
    Kaminski JP, Maker VK, Maker AV
    J Am Coll Surg. 2013 Nov; 217(5):929-39.; 
    PubMed
  109. A technique for laparoendoscopic resection of posterior fundic gastric GISTs without need for a gastrotomy.
    Maker AV
    Ann Surg Oncol. 2013 Dec; 20(13):4238.; 
    PubMed
  110. Survival after resection of cutaneous adnexal carcinomas with eccrine differentiation: risk factors and trends in outcomes.
    Avraham JB, Villines D, Maker VK, August C, Maker AV
    J Surg Oncol. 2013 Jul; 108(1):57-62.; 
    PubMed
  111. Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases.
    Qin JZ, Upadhyay V, Prabhakar B, Maker AV
    J Transl Med. 2013 Mar 20; 11:70.; 
    PubMed
  112. MADD knock-down enhances doxorubicin and TRAIL induced apoptosis in breast cancer cells.
    Turner A, Li LC, Pilli T, Qian L, Wiley EL, Setty S, Christov K, Ganesh L, Maker AV, Li P, Kanteti P, Das Gupta TK, Prabhakar BS
    PLoS One. 2013; 8(2):e56817.; 
    PubMed
  113. Primary hepatic lymphoma presenting as an isolated solitary hepatic cyst.
    Valladolid G, Adams LL, Weisenberg E, Maker VK, Maker AV
    J Clin Oncol. 2013 Jan 10; 31(2):e21-3.; 
    PubMed
  114. Can we predict which residents are going to pass/fail the oral boards?
    Maker VK, Zahedi MM, Villines D, Maker AV
    J Surg Educ. 2012 Nov-Dec; 69(6):705-13.; 
    PubMed
  115. Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases.
    Katz SC, Bamboat ZM, Maker AV, Shia J, Pillarisetty VG, Yopp AC, Hedvat CV, Gonen M, Jarnagin WR, Fong Y, D'Angelica MI, DeMatteo RP
    Ann Surg Oncol. 2013 Mar; 20(3):946-55.; 
    PubMed
  116. Malignant masquerade of xanthogranulomatous cholecystitis on intraoperative ultrasound of the liver.
    Maker AV, Maker VK
    J Surg Oncol. 2012 Sep 15; 106(4):525-6.; 
    PubMed
  117. Video: totally laparoscopic left lateral segmentectomy for hepatic malignancies: a modified technique.
    Maker AV, Jamal W, Gayet B
    J Gastrointest Surg. 2011 Sep; 15(9):1650.; 
    PubMed
  118. Is port site resection necessary in the surgical management of gallbladder cancer?
    Maker AV, Butte JM, Oxenberg J, Kuk D, Gonen M, Fong Y, Dematteo RP, D'Angelica MI, Allen PJ, Jarnagin WR
    Ann Surg Oncol. 2012 Feb; 19(2):409-17.; 
    PubMed
  119. Knockdown of MADD and c-FLIP overcomes resistance to TRAIL-induced apoptosis in ovarian cancer cells.
    Li LC, Jayaram S, Ganesh L, Qian L, Rotmensch J, Maker AV, Prabhakar BS
    Am J Obstet Gynecol. 2011 Oct; 205(4):362.e12-25.; 
    PubMed
  120. Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas.
    Maker AV, Katabi N, Qin LX, Klimstra DS, Schattner M, Brennan MF, Jarnagin WR, Allen PJ
    Clin Cancer Res. 2011 Mar 15; 17(6):1502-8.; 
    PubMed
  121. Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas.
    Maker AV, Katabi N, Gonen M, DeMatteo RP, D'Angelica MI, Fong Y, Jarnagin WR, Brennan MF, Allen PJ
    Ann Surg Oncol. 2011 Jan; 18(1):199-206.; 
    PubMed
  122. Randomized clinical trials in pancreatic adenocarcinoma.
    Rudloff U, Maker AV, Brennan MF, Allen PJ
    Surg Oncol Clin N Am. 2010 Jan; 19(1):115-50.; 
    PubMed
  123. Novel presentation of a familial pancreatic cancer syndrome.
    Maker AV, Warth JA, Zinner MJ
    J Gastrointest Surg. 2009 Jun; 13(6):1151-4.; 
    PubMed
  124. Cytology from pancreatic cysts has marginal utility in surgical decision-making.
    Maker AV, Lee LS, Raut CP, Clancy TE, Swanson RS
    Ann Surg Oncol. 2008 Nov; 15(11):3187-92.; 
    PubMed
  125. Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma.
    Maker AV, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Hughes M, Yellin MJ, Haworth LR, Levy C, Allen T, Mavroukakis SA, Attia P, Rosenberg SA
    J Immunother. 2006 Jul-Aug; 29(4):455-63.; 
    PubMed
  126. Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2.
    Attia P, Powell DJ, Maker AV, Kreitman RJ, Pastan I, Rosenberg SA
    J Immunother. 2006 Mar-Apr; 29(2):208-14.; 
    PubMed
  127. Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade.
    Maker AV, Attia P, Rosenberg SA
    J Immunol. 2005 Dec 01; 175(11):7746-54.; 
    PubMed
  128. Images in cardiothoracic surgery. Active malignant pleural effusion captured through the thoracoscope.
    Maker AV, Nguyen DM
    Ann Thorac Surg. 2005 Nov; 80(5):1941.; 
    PubMed
  129. Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma.
    Attia P, Maker AV, Haworth LR, Rogers-Freezer L, Rosenberg SA
    J Immunother. 2005 Nov-Dec; 28(6):582-92.; 
    PubMed
  130. Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study.
    Maker AV, Phan GQ, Attia P, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Haworth LR, Levy C, Kleiner D, Mavroukakis SA, Yellin M, Rosenberg SA
    Ann Surg Oncol. 2005 Dec; 12(12):1005-16.; 
    PubMed
  131. Loss of S100 antigenicity in metastatic melanoma.
    Aisner DL, Maker A, Rosenberg SA, Berman DM
    Hum Pathol. 2005 Sep; 36(9):1016-9.; 
    PubMed
  132. Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.
    Attia P, Phan GQ, Maker AV, Robinson MR, Quezado MM, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Restifo NP, Haworth LR, Levy C, Mavroukakis SA, Nichol G, Yellin MJ, Rosenberg SA
    J Clin Oncol. 2005 Sep 01; 23(25):6043-53.; 
    PubMed
  133. Rapid acute amiodarone-induced hepatotoxicity in a burn patient.
    Maker AV, Orgill DP
    J Burn Care Rehabil. 2005 Jul-Aug; 26(4):341-3.; 
    PubMed
  134. Insulin receptor (IR) and glucose transporter 2 (GLUT2) proteins form a complex on the rat hepatocyte membrane.
    Eisenberg ML, Maker AV, Slezak LA, Nathan JD, Sritharan KC, Jena BP, Geibel JP, Andersen DK
    Cell Physiol Biochem. 2005; 15(1-4):51-8.; 
    PubMed